Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites

Graeme Eisenhofer; Aleksander Prejbisz; Mirko Peitzsch; Christina Pamporaki; Jimmy Masjkur; Natalie Rogowski-Lehmann; Katharina Langton; Elena Tsourdi; Mariola Peczkowska; Stephanie Fliedner; Timo Deutschbein; Felix Megerle; Henri JLM Timmers; Richard Sinnott; Felix Beuschlein; Martin Fassnacht; Andrzej Januszewicz; Jacques WM Lenders

Journal article

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites

Graeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, Christina Pamporaki, Jimmy Masjkur, Natalie Rogowski-Lehmann, Katharina Langton, Elena Tsourdi, Mariola Peczkowska, Stephanie Fliedner, Timo Deutschbein, Felix Megerle, Henri JLM Timmers, Richard Sinnott, Felix Beuschlein, Martin Fassnacht, Andrzej Januszewicz, Jacques WM Lenders

Clinical Chemistry | AMER ASSOC CLINICAL CHEMISTRY | Published : 2018

DOI: 10.1373/clinchem.2018.291369

University of Melbourne Researchers

Richard Sinnott Author Computing and Information Systems

Grants

Awarded by Deutsche Forschungsgemeinschaft

Awarded by Entity: European Union Seventh Framework Programme (FP7/2007-2013)

Awarded by European Union Horizon 2020 Program (ENS@T-HT)

Funding Acknowledgements

Deutsche Forschungsgemeinschaft (CRC/Transregio 205/1), Entity: European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 259735, European Union Horizon 2020 Program (ENS@T-HT - #633983-2), Institute of Cardiology. G. Eisenhofer, Deutsche Forschungsgemeinschaft (EI855/1/2, KFO252).